Diabetes accounts for one third or more of all new end stage renal disease in the United States and accounts for at least 16 % of all new patients going onto renal replacement therapy in Europe [1] . The most common cause of end stage renal disease in diabetes is diabetic glomerulosclerosis (nephropathy).
WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD) is a prospective study designed to examine the frequency of diabetic complications and identify risk factors for their development and outcome in Type I (insulin-dependent) and Type II (non-insulin dependent) diabetes mellitus. The study started in 1975 and follow-up of deaths ended in 1988. With over 43 670 person years of follow-up it is in a unique position to provide information on risk factors for renal failure. Another paper in this supplement focuses on risk factors for and prevalence of albuminuria, an early marker of renal failure, for which only prevalence data rather than incidence data were available [4] .
Subjects and methods
Methods of patient selection and examination for the WHO MSVDD have been described in the first paper in this series [5] and in detail previously [6, 7] . The risk factors for renal failure included in this analysis were cigarette smoking, blood pressure, serum cholesterol and triglyceride, plasma glucose, proteinuria, retinopathy and ECG abnormalities. The methods of assessing these factors are described elsewhere [5] . For the present analysis categories of retinopathy have been combined into two: any retinopathy or none. Three degrees of proteinuria (heavy, light or none) were defined by the salicylsulphonic acid test, in which the degree of turbidity caused by precipitation of protein was assessed visually and classified as light to heavy on a single spot-urine sample [6, 7] . Light proteinuria was considered present if there was slight turbidity on precipitation assessed visually. Heavy proteinuria was considered present if there was a distinct or heavy turbidity or a flocculent precipitate. If there was no turbidity then proteinuria was considered absent. For between-centre comparisons patients were grouped according to four geographical regions, i. e. European (London, Switzerland, Berlin, Warsaw and Zagreb); East Asian (Hong Kong and Tokyo); Cuban (Havana) and American Indian (Oklahoma and Arizona).
By the 1 st of January 1988 vital status had been ascertained for at least 95 % of the original participants. Those who were alive had a second examination at which whether the patient had renal failure or was receiving renal support (dialysis or transplantation) was recorded. For those alive but not examined, medical records were reviewed for a history of renal failure [5] .
For this analysis renal failure was defined as receiving renal support or having a history of renal failure at morbidity followup, or death where ICD-9 codes 580±589 (nephritis, nephrosis and nephrotic syndrome) or 250.3 (diabetic nephropathy) were mentioned anywhere on the final categorisation of cause of death (i. e. either as underlying or contributory cause of death).
Statistical analysis. To examine the association between renal failure and risk factors age standardised incidence rates (per 1000 person years) were calculated by each category of risk factor, where the rates were directly standardised to the age distribution of the whole sample. Those with heavy proteinuria at baseline were considered to have renal disease and were therefore excluded from this analysis of the incidence of renal failure.
Using the Cox proportional hazard model, age adjusted relative risks (RRs) were also calculated for each category. The relative risk was calculated as the exponent of the beta coefficient of the risk factor in the Cox proportional hazards model, where the model contained the risk factor as a categorical variable and age as a covariate. For continuous variables, initially the distribution was split into categories and the RR was the risk of an event associated with having a value in that particular category relative to the risk of an event associated with having a value in the lowest category. For categorical variables the RR was the risk of an event associated with each category relative to the risk of an event when that risk factor was absent. Any associations were considered statistically significant if the 95 % confidence interval (CI) did not include a value of 1 (i. e. p < 0.05). For continuous risk factors the standardised estimates of relative risk (SRRs), adjusted for age, were also calculated. These were the relative risks associated with an increase in 1 standard deviation of the risk factor, again estimated by the Cox proportional hazard model.
To assess the independent association of all risk factors with renal failure, multivariate Cox proportional hazards modeling was carried out. Age, sex and duration of diabetes, were included as covariates in the model and the roles of systolic blood pressure, proteinuria and retinopathy were investigated as risk factors for renal failure.
Because serum triglyceride and plasma glucose were only measured in a sub-sample of 1778 and 2286 patients respectively, the above modeling was repeated first with triglycerides (Model 2) then with fasting plasma glucose (Model 3) included. Serum triglyceride and plasma glucose were log transformed in these analyses because their distributions were skewed. All analyses were done using the SAS statistical package. A p value of less than 0.05 was considered statistically significant.
Results
There were 4743 participants at baseline in the 10 centres who participated in the morbidity and mortality follow-up. Of these, 516 had either heavy proteinuria or a history of renal failure at baseline and were excluded from this analysis. A further 24 had no morbidity or mortality information. A further 645 participants were known to be alive by close of follow-up but their renal status was not known. These were excluded from the analysis. The risk factor profile (cholesterol, triglycerides, blood pressure) of those excluded was more similar to the group that did not subsequently develop renal failure than those who did.
Thus for this analysis of renal failure 3 558 diabetic patients were followed-up (1 705 men and 1 853 women), of whom 959 were classified as having Type I diabetes and 2599 as having Type II diabetes. The average follow-up was 8.4 years ( 2.7). By the end of follow-up 187 people (53 with Type I, 134 with Type II diabetes) had developed renal failure (Table 1), an incidence rate of 6.3 per 1000 person years. Of these 87 were defined on the basis of a renal disease death and 100 were noted to have renal failure at morbidity follow-up. Of those with renal failure at morbidity follow-up, 47 had died , 30 of whom had renal disease noted as either underlying or contributory cause of death.
The numbers of events and age-adjusted event rates for renal failure by type of diabetes are shown in Table 1 . Renal failure rates, adjusted for age, were higher in those with Type I diabetes (7.6:1000 person years) than in those with Type II diabetes (5.9:1000 person years, p = 0.003). To assess whether renal failure rates were similar across centres, rates were compared by the four geographical regions. Compared with those in Europe, patients with Type I diabetes from East Asia and Cuba had higher renal failure incidence, adjusted for age (Table 1) . Among those with Type II diabetes, Native Americans had a higher incidence of renal failure than those from Europe, adjusted for age (Table 1) .
Baseline risk factors and age-adjusted renal failure (Table 2 ). In Type I diabetes, age (RR for one year = 1.03, p = 0.24) and duration (RR for one year = 1.02, p = 0.21) were similarly predictive of renal failure. In Type II diabetes duration was more strongly predictive of renal failure than age (RR for age = 1.03, p = 0.07, RR for duration = 1.09 p < 0.001). Renal failure rates were higher in men than in women both for patients with Type I diabetes (6.2 and 7.9: 1000 person years for men and women respectively) and with Type II diabetes (5.0 and 6.8: 1000 person years for men and women respectively) but these differences were not statistically significant.
For Type I diabetic patients, factors at baseline related to age-adjusted renal failure were systolic blood pressure, the presence of retinopathy and light proteinuria (Table 2 ). Smoking status, triglycerides, cholesterol, ECG abnormalities and plasma glucose did not show any association with renal failure. There were no differences between sexes in the pattern of these associations.
Among those with Type II diabetes, higher triglycerides and plasma glucose were associated with age adjusted renal failure, whereas systolic blood pressure, total cholesterol, abnormal ECG and smoking were not ( Table 2 ). The presence of retinopathy and light proteinuria at baseline were also predictive of renal failure. There were no differences in the pattern of these associations between the sexes (data not shown). As there was little difference in the univariate associations between sexes, the multivariate analyses were carried out for both sexes combined with adjustment for sex in the model.
The age-adjusted analysis of the association of the factors in Table 2 with renal failure was repeated excluding deaths where renal disease was mentioned on the death certificate but was not the underlying cause of death. The pattern of associations was unchanged except that the magnitude of the association of triglycerides with renal failure increased slightly in those with Type II diabetes.
Baseline risk factors and renal failure-multivariate analysis. Since self-reported smoking, ECG status and cholesterol were not associated with renal failure adjusted for age, duration, and sex, they were not included in the subsequent models. Table 3 shows the relative risks for renal failure estimated from the Cox proportional hazards model including age, duration, and sex as covariates and including systolic blood pressure, with further adjustment for proteinuria and retinopathy (Model 1) and with the inclusion of triglycerides (Model 2) and fasting plasma glucose (Model 3).
In Type I but not Type II diabetic patients, systolic blood pressure was associated with renal failure independent of baseline proteinuria and also of retinopathy. There was no interaction between retinopathy and systolic blood pressure. In Type I and Type II diabetic retinopathy and baseline proteinuria were strongly and independently associated with renal failure. Model 2 contained the same variables as Model 1 with the addition of triglycerides. Since there was no association between triglycerides and renal failure in Type I diabetes this model was only carried out for Type II diabetes. Triglycerides were independently associated with renal failure even after adjusting for proteinuria, retinopathy and systolic blood pressure. There was no interaction between the effect of tri- (Table 3) were carried out using hypertension (defined as a systolic blood pressure ³ 140 mmHg or a diastolic blood pressure ³ 90 mmHg or on anti-hypertensive therapy) instead of systolic blood pressure, the conclusions did not alter. For Type I diabetic patients the age adjust- a Number of CVD deaths; b Age-adjusted rate per 1,000 person years; c p value relates to the significance of the risk factor as a continuous variable ed RR (95 % CI) was 2.2 (1.2, 4.0) and for Type II diabetic patients it was 1.1 (0.8, 1.6). The multivariate analysis showed that, for Type I diabetic patients, the RR (95 %) for hypertension in Model 1 was 1.8 (1.0, 1.3). For Type II diabetic patients the RRs (95 %) for hypertension, in Models 1, 2 and 3 were 1.0 (0.7, 1.4), 0.9 (0.6, 1.3) and 0.8 (0.5, 1.3), respectively. Table 4 shows the effect of adjusting for various risk factors on the difference in incidence of renal failure between the Native American group and patients with Type II diabetes from European Centres. Adjusted for diabetes duration, age and sex, Native Americans had more than twice the risk of developing renal failure (RR = 2.09). There was little attenuation of this risk on adjustment for baseline retinopathy, systolic blood pressure or light proteinuria (Table 4, Model 1). In Model 2 and Model 3, although the relative risks associated with Native American ethnicity are similar, because there are fewer subjects in the analysis the association with ethnicity does not reach statistical significance on adjustment for age, diabetes duration and sex. However it seems that plasma glucose is the most important determinant of the ethnic difference in risk since adjustment for glucose attenuates the relative risk to 1.1.
Discussion
These data confirm the well-recognised importance of proteinuria as a predictor of renal failure in both Type I [9±12] and Type II diabetes [13, 14] . Light proteinuria was associated with a threefold increased risk of renal failure in patients with Type I diabetes and a twofold increase among those with Type II diabetes, adjusted for age. Although the salicylsulphonic acid test is no longer used it has been shown to have 100 % sensitivity and 85 % specificity for detecting urinary albumin at 30 mg/l concentration (compara- ble with the current definition of microalbuminuria) [15] . Those with heavy proteinuria at baseline were excluded because they were likely to have overt diabetic nephropathy. These data also support the role of hyperglycaemia as a determinant of renal failure in Type II diabetic patients and thus the importance of maintaining optimal glycaemic control in this group. This finding is consistent with the many studies both cross-sectional [16] and prospective [17±20] showing that the degree of hyperglycaemia (measured as glycated Hb) predicts either overt nephropathy or microalbuminuria in Type I and Type II diabetes. As a single fasting plasma glucose estimation was used, we were unable to assess the role of long-term glycaemic control in renal failure in Type I diabetes.
There has been considerable argument about the extent to which blood pressure has a causal role in diabetic nephropathy as distinct from being a consequence of it [21] . In other studies blood pressure was found to be higher in patients with microalbuminuria (before GFR decreases) than in those with normoalbuminuria, [10, 22, 23] but a Danish study suggested that blood pressure does not rise until microalbuminuria has been established for several years [24] . Studies showing that a parental history of hypertension is associated with nephropathy in the offspring [25, 26, 44] suggest that, at least to some extent, elevations in blood pressure precede the onset of renal disease. In addition, some studies show that Type I diabetic patients who develop nephropathy have higher blood pressures in adolescence [27, 28] . In our data systolic blood pressure predicts renal failure even after adjusting for degrees of proteinuria at baseline but in Type I diabetic patients only. A systolic blood pressure one standard deviation above the mean was associated with a 50 % higher risk of renal failure in Type I diabetes, after adjusting for other factors (Model 1, Table 3 ). Systolic blood pressure was not predictive of renal failure in Type II diabetic patients even before adjustment for baseline proteinuria. Similarly hypertension defined as a SBP of 140 mmHg or more, or a DBP of 90 mmHg or more, or use of antihypertensive medications was predictive of renal failure in Type I diabetic but not Type II diabetic patients. It should be noted that in our study as in others, casual blood pressure measurements were made rather than ambulatory measurements which could be more sensitive for the detection of hypertension.
In this study retinopathy was a predictor of renal failure even after adjusting for baseline proteinuria, systolic blood pressure, age, duration, and, in Type II diabetes, fasting blood glucose and triglycerides. The presence and severity of retinopathy could simply be a marker of the intensity of the microangiopathic process, driven by poor glycaemic control interacting with individual susceptibility [29] . This is reflected by the clustering of vascular complications. In the EURODIAB Type I Complications Study there was an increase in albumin excretion rate with increasing systolic blood pressure only among those with retinopathy [30] but no such interaction was observed in this study.
In neither Type I nor Type II diabetes did we find any association between self-reported smoking (past or current) and renal failure either before or after adjusting for other possible risk factors. In contrast in the EURODIAB Type I Complications Study current smoking was associated with albuminuria [31] , a finding consistent with most [32±35] but not all [36] other studies.
Low density lipoprotein (LDL) cholesterol and triglycerides increase with the onset of renal disease [37, 38] , even at an early stage. A causal role for dyslipidaemia in nephropathy in Type I diabetes was suggested by the Pittsburgh Epidemiology of Diabetes Complications Study, which found that LDL and triglycerides predicted the development of albuminuria [17] . In Pima Indians, raised total plasma cholesterol predicted increased albumin excretion (data on triglycerides were not available) [18] . In the present study total cholesterol at baseline was not predictive of renal failure. In Type I diabetic patients the incidence of renal failure did increase with baseline triglyceride concentration (Table 2 ) but this association was not statistically significant. Among those with Type II diabetes, triglyceride concentrations were associated with renal failure independently of other risk factors including proteinuria at baseline. Indeed, in Type II diabetic patients triglycerides were more closely associated with renal failure than arterial pressure. There are several possible explanations for the association. Higher triglycerides could simply reflect poorer glycaemic control not fully accounted for by fasting plasma glucose (i. e. residual confounding). However, the WHO Multinational Study is large enough and of sufficiently long duration to detect associations that might have gone undetected in studies with less power and there are several biologically plausible mechanisms by which triglycerides could be truly predictive of renal disease. Raised triglycerides are associated with increased formation of small dense low density lipoproteins [39, 40] which in turn have increased susceptibility to oxidation and which could initiate endothelial damage and thus renal disease. Alternatively it is possible that the association between triglycerides and renal failure could have arisen because higher triglycerides are associated with higher concentrations of non-esterified fatty acids (NEFA). Non-esterified fatty acids have been shown to impair endothelial function, probably by inhibiting nitric oxide production [41, 42] and decreased nitric oxide production is associated with the development of diabetic nephropathy in diabetic spontaneously hypertensive rats [43] . Thus it is possible to speculate that high triglycerides could be a marker of impaired nitric oxide production with consequent renal damage.
The high renal failure rate in American Indians has been reported previously and is consistent with the higher incidence of renal failure in this group [4] . Our analysis shows that plasma glucose appears to be the most important determinant of this increased risk and suggest that triglycerides could also be involved (Table 4) .
Our data have several limitations. It is possible that renal failure was unrecognised as a cause of some of the deaths reported. However, such underascertainment would reduce the power to detect associations with risk factors rather than creating spurious associations. We attempted to exclude those with established renal failure at baseline by excluding anyone with heavy proteinuria. It is possible, however, that some of the observed risk-factor associations reflect a secondary rise in risk factors in those with incipient renal disease at baseline. However, because the associations observed were all independent of even light proteinuria at baseline this is not likely.
A total of 645 patients who were alive at follow-up but whose renal status was not known were excluded from this analysis. The estimate of the incidence of renal failure could be either an underestimation (if all these 645 actually had renal failure) or an overestimation (if none of these 645 had renal failure). Slight overestimation is more likely, as the baseline risk factor profile of this group was more similar to those who did not subsequently develop renal failure than those who did.
In summary we have confirmed the role of proteinuria and retinopathy as markers of renal failure. The importance of hyperglycaemia in renal failure in Type II diabetes has been shown. Evidence has been found for a potentially important role for triglycerides as a predictor of renal failure in Type II diabetes.
